U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
7833178331Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol®CompletedNo Results AvailableHealthy SubjectsDrug: Marketed paracetamol|Drug: Experimental paracetamol formulationhttps://ClinicalTrials.gov/show/NCT01540734
7833278332Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® ExtendCompletedNo Results AvailableHealthy SubjectsDrug: Marketed paracetamol|Drug: Experimental paracetamol formulationhttps://ClinicalTrials.gov/show/NCT01540721
7833378333A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/SalmeterolCompletedNo Results AvailableAsthmaDrug: SERETIDE Rotacaps|Drug: SERETIDE Diskushttps://ClinicalTrials.gov/show/NCT01540708
7833478334Does Cryofixation of Skin Specimens Affect Quality of Subsequent Formalin Fixed Paraffin Embedded H and E HistologyCompletedNo Results AvailableBasal Cell Carcinoma|Squamous Cell Carcinomahttps://ClinicalTrials.gov/show/NCT01540695
7833578335MLN8237 in Head and Neck CancerCompletedNo Results AvailableHead and Neck CancerDrug: MLN8237|Drug: Cetuximab|Radiation: Radiotherapyhttps://ClinicalTrials.gov/show/NCT01540682
7833678336Dose-Responsive Effect of Polydextrose on Whole Gut Transit TimeActive, not recruitingNo Results AvailableFunctional ConstipationDietary Supplement: Polydextrose, low dose|Dietary Supplement: Polydextrose, medium dose|Dietary Supplement: Polydextrose, high dose|Dietary Supplement: Placebo powderhttps://ClinicalTrials.gov/show/NCT01540669
7833778337Mechanical Nerve Stimulation in the Treatment of Post Prostatectomy IncontinenceActive, not recruitingNo Results AvailableUrinary Incontinence|Radical ProstatectomyDevice: Transcutaneous mechanical nerve stimulation (TMNS) (FERTI CARE)https://ClinicalTrials.gov/show/NCT01540656
7833878338Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market RegistryActive, not recruitingNo Results AvailableAbdominal Aortic Aneurysm|Aorto-iliac AneurysmDevice: Iliac Leg Grafthttps://ClinicalTrials.gov/show/NCT01540643
7833978339A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal NeuralgiaCompletedNo Results AvailableTrigeminal NeuralgiaDrug: CNV1014802|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01540630
7834078340The Neural Basis of Lumbosacral Proprioceptive Impairment in Recurrent Low Back PainCompletedNo Results AvailableLow Back Painhttps://ClinicalTrials.gov/show/NCT01540617
7834178341CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic CarriersCompletedNo Results AvailableDuchenne Muscular Dystrophy|Becker Muscular DystrophyDrug: CRD007https://ClinicalTrials.gov/show/NCT01540604
7834278342Intralipid for Repeated Implantation FailureCompletedNo Results AvailableInfertilityDrug: intralipidhttps://ClinicalTrials.gov/show/NCT01540591
7834378343Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic LeukemiaRecruitingNo Results AvailableB-cell Childhood Acute Lymphoblastic Leukemia|Childhood Acute Lymphoblastic Leukemia in Remission|Recurrent Childhood Acute Lymphoblastic LeukemiaOther: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT01540578
7834478344Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerActive, not recruitingNo Results AvailableBRCA1 Mutation Carrier|BRCA2 Mutation Carrier|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Primary Peritoneal CarcinomaOther: Laboratory Biomarker Analysis|Drug: Veliparibhttps://ClinicalTrials.gov/show/NCT01540565
7834578345Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung CancerCompletedNo Results AvailableLung Cancer|Precancerous ConditionOther: medical chart review|Procedure: computed tomography|Procedure: computer-aided detection/diagnosishttps://ClinicalTrials.gov/show/NCT01540552
7834678346Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy VolunteersCompletedNo Results AvailableHealthy VolunteersDrug: REGN1154 or placebohttps://ClinicalTrials.gov/show/NCT01540539
7834778347Pharmacodynamic Study With FLT-PET/CT in Patients With Prostate/Other Solid Malignancies Treated With High Dose AxitinibCompletedNo Results AvailableSolid Malignancies|Metastatic Castrate-resistant Prostate CancerDrug: axitinibhttps://ClinicalTrials.gov/show/NCT01540526
7834878348PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404TerminatedNo Results AvailableGlioblastoma Multiforme|Brain MetastasesDrug: NM404|Drug: NM404https://ClinicalTrials.gov/show/NCT01540513
7834978349Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, FluvoxamineCompletedNo Results AvailableHealthy VolunteersDrug: Tasimelteon|Drug: Fluvoxaminehttps://ClinicalTrials.gov/show/NCT01540500
7835078350Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /MetforminCompletedHas ResultsHealthyDrug: linagliptin/metformin(high dose)|Drug: Linagliptin/metformin(low dose)https://ClinicalTrials.gov/show/NCT01540487
7835178351Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive AdultsCompletedNo Results AvailableMalariaBiological: Group 1: 10 ug FMP012 with 2 ug GLA-SE|Biological: Group 2: 10 ug FMP012 with 5 ug GLA-SE|Biological: 50 ug FMP012 with 5 ug GLA-SE or 2 ug GLA-SEhttps://ClinicalTrials.gov/show/NCT01540474
7835278352Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC)CompletedNo Results AvailableHepatocellular CarcinomaDrug: Brivanibhttps://ClinicalTrials.gov/show/NCT01540461
7835378353Role of CT Angiography With Three-dimensional Reconstruction of Mesenteric Vessels in Planning and Performing of Laparoscopic Colorectal ResectionsCompletedNo Results AvailableColorectal Laparoscopic ResectionProcedure: Laparoscopic Right Hemicolectomy|Procedure: Laparoscopic Left Hemicolectomy|Procedure: Anterior Rectal Resectionhttps://ClinicalTrials.gov/show/NCT01540448
7835478354Perioperative Treatment of Resectable Liver MetastasesWithdrawnNo Results AvailableColon Cancer Liver MetastasisDrug: Bevacizumabhttps://ClinicalTrials.gov/show/NCT01540435
7835578355Study to Improve Long Term Vein Graft Patency After Coronary Bypass Surgery by Using a Novel Endoscopic Harvesting TechniqueCompletedNo Results AvailableCoronary Artery Diseasehttps://ClinicalTrials.gov/show/NCT01540422
7835678356Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular DystrophyActive, not recruitingNo Results AvailableDuchenne Muscular Dystrophy (DMD)Drug: AVI-4658 (Eteplirsen)https://ClinicalTrials.gov/show/NCT01540409
7835778357Gestational Diabetes Diagnostic MethodsActive, not recruitingNo Results AvailableGestational DiabetesBehavioral: Dietary modification and medicationshttps://ClinicalTrials.gov/show/NCT01540396
7835878358Effectiveness of Intensive Aphasia Therapy Under Routine Clinical ConditionsCompletedNo Results AvailableAphasia|StrokeBehavioral: Intensive integrative aphasia therapy|Behavioral: Waiting list control grouphttps://ClinicalTrials.gov/show/NCT01540383
7835978359Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT)CompletedHas ResultsGlaucoma, Open-Angle|Ocular HypertensionOther: No Treatmenthttps://ClinicalTrials.gov/show/NCT01540370
7836078360Mindfulness-based Therapy in Chronic TinnitusCompletedNo Results AvailableChronic TinnitusBehavioral: Mindfulness-based therapy|Behavioral: Treatment after waiting timehttps://ClinicalTrials.gov/show/NCT01540357

* Görseller ve İçerik tekif hakkına sahip olabilir